Completed NCT04972227
This study is completed in the United States. It is testing Safety and Pharmacokinetics of CY6463 for schizophrenia.
Multiple locations, including Long Beach Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 50 Years
Countries United States
Sponsor Tisento Therapeutics
Condition Schizophrenia Completed NCT02411695
This study is completed in the United States. It is testing Brexpiprazole (OPC- 34712) for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 13 Years to 17 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT00690274
This summary needs review. Please check the official study record and contact the research team for details.
In Dallas Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor University of Texas Southwestern Medical Center
Condition Schizophrenia Completed NCT03397134
This study is completed in the United States, in Bulgaria, in Poland, .... It is testing roluperidone for schizophrenia.
Multiple locations, including Rogers Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries United States, Bulgaria, Poland, ...
Sponsor Minerva Neurosciences
Condition Schizophrenia Terminated NCT02261519
This study was terminated in the United States. It is testing safety & Efficacy of NaBen® for schizophrenia.
In Pasadena Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 45 Years
Countries United States
Sponsor SyneuRx International (Taiwan) Corp
Condition Schizophrenia Completed NCT03160521
This study is completed in the United States and in Ukraine. It is testing risperidone for schizophrenia.
Multiple locations, including Rogers Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Ukraine
Sponsor Rovi Pharmaceuticals Laboratories
Condition Schizophrenia Completed NCT03870880
This study is completed in the United States and in Ukraine. It is testing Risperidone ISM® for schizophrenia.
Multiple locations, including Rogers Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Ukraine
Sponsor Rovi Pharmaceuticals Laboratories
Condition Schizophrenia Terminated NCT05182476
This study was terminated in the United States, in Bulgaria, in Czechia, .... It is testing efficacy, Safety, and Tolerability of Luvadaxistat for schizophrenia.
Multiple locations, including Phoenix Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 50 Years
Countries United States, Bulgaria, Czechia, ...
Sponsor Neurocrine Biosciences
Condition Schizophrenia Terminated NCT05654870
This study was terminated in the United States. It is testing efficacy, Safety, and Tolerability of Valbenazine for schizophrenia.
Multiple locations, including San Jose Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 13 Years
Countries United States
Sponsor Neurocrine Biosciences
Condition Schizophrenia Completed NCT03201757
This study is completed in the United States, in the United Kingdom, in Austria, .... It focuses on Schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia, Bipolarity Drug From 16 Years to 70 Years
Countries United States, United Kingdom, Austria, ...
Sponsor Alkermes, Inc.
Condition Schizophrenia, Bipolarity Completed NCT03503318
This study is completed in the United States and in Bulgaria. It is testing TV-46000 for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 13 Years to 65 Years
Countries United States, Bulgaria
Sponsor Teva Branded Pharmaceutical Products R&D, Inc.
Condition Schizophrenia Completed NCT04010305
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor BioXcel Therapeutics Inc
Condition Schizophrenia